MedPath

Ventilator Settings and Outcomes in Pediatric Patients on ECMO for Severe Respiratory Failure

Active, not recruiting
Conditions
Critical Illness
Respiratory Failure (Pediatric Patients)
Registration Number
NCT06899009
Lead Sponsor
University Medical Center Groningen
Brief Summary

This study aims to describe the effects of ECMO initiation on the intensity of ventilation in the first 24 hours after ECMO initiation and to explore associations between changes in ventilation intensity and hospital mortality in critically ill pediatric patients requiring ECMO for respiratory failure, using the 'Extracorporeal Life Support Organization' (ELSO) registry.

Detailed Description

Rationale:

Despite the growing use of ECMO in critically ill pediatric patients, uncertainties remain to what extent adjustments of ventilator settings after ECMO initiation are associated with mortality.

Objectives:

1. To describe the effects of ECMO initiation on the intensity of ventilation in the first 24 hours after ECMO initiation; and

2. To explore associations between changes in ventilation intensity and hospital mortality in critically ill pediatric patients requiring ECMO for respiratory failure

Hypothesis:

1. Ventilation intensity decreases following initiation of ECMO; and

2. A decrease in ventilation intensity is associated with lower hospital mortality in critically ill pediatric patients.

Study design:

This is a posthoc analysis of the ELSO registry.

Study population:

For this analysis, data will be obtained from the ELSO registry. All pediatric patients (aged ≥29 days to ≤18 years) receiving ECMO for a pulmonary indication between January 1, 2012, and December 31, 2022 will be included. Patients with missing ventilatory variables required to assess ventilation intensity and patients lost to follow up with respect to hospital mortality will be excluded.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
750
Inclusion Criteria
  1. Patients (aged ≥29 days to ≤18 years) receiving ECMO between January 1, 2012, and December 31, 2022, in an ELSO affiliated center; and
  2. Requiring ECMO for a pulmonary indication.
Exclusion Criteria
  1. Patients with missing ventilatory variables required to assess ventilation intensity;
  2. patients who were lost to follow up with respect to hospital mortality.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital mortalityUp to 90 days of study or whatever comes first
Secondary Outcome Measures
NameTimeMethod
Hospital length of stayUp to 90 days of study or whatever comes first
Duration of ECMO runUp to 90 days of study or whatever comes first
Duration of invasive ventilationUp to 90 days of study or whatever comes first

Trial Locations

Locations (1)

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

University Medical Center Groningen
🇳🇱Groningen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath